- Home
- ATAI vs AMPX Comparison
ATAI vs AMPX Comparison
Compare ATAI & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- AMPX
- Stock Information
- Founded
- ATAI 2018
- AMPX 2008
- Country
- ATAI Germany
- AMPX United States
- Employees
- ATAI N/A
- AMPX N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- AMPX Industrial Machinery/Components
- Sector
- ATAI Health Care
- AMPX Miscellaneous
- Exchange
- ATAI Nasdaq
- AMPX Nasdaq
- Market Cap
- ATAI 282.6M
- AMPX 261.6M
- IPO Year
- ATAI 2021
- AMPX N/A
- Fundamental
- Price
- ATAI $2.49
- AMPX $2.64
- Analyst Decision
- ATAI Strong Buy
- AMPX Strong Buy
- Analyst Count
- ATAI 3
- AMPX 7
- Target Price
- ATAI $10.50
- AMPX $8.71
- AVG Volume (30 Days)
- ATAI 2.4M
- AMPX 3.3M
- Earning Date
- ATAI 05-14-2025
- AMPX 05-08-2025
- Dividend Yield
- ATAI N/A
- AMPX N/A
- EPS Growth
- ATAI N/A
- AMPX N/A
- EPS
- ATAI N/A
- AMPX N/A
- Revenue
- ATAI $1,863,000.00
- AMPX $33,115,000.00
- Revenue This Year
- ATAI $242.21
- AMPX $160.31
- Revenue Next Year
- ATAI N/A
- AMPX $224.32
- P/E Ratio
- ATAI N/A
- AMPX N/A
- Revenue Growth
- ATAI 572.56
- AMPX 209.20
- 52 Week Low
- ATAI $1.03
- AMPX $0.61
- 52 Week High
- ATAI $2.64
- AMPX $4.21
- Technical
- Relative Strength Index (RSI)
- ATAI 80.34
- AMPX 50.95
- Support Level
- ATAI $2.18
- AMPX $2.34
- Resistance Level
- ATAI $2.38
- AMPX $3.17
- Average True Range (ATR)
- ATAI 0.20
- AMPX 0.20
- MACD
- ATAI 0.07
- AMPX 0.01
- Stochastic Oscillator
- ATAI 88.14
- AMPX 35.54
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.